Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Sales | 4,195 | 4,944 | 4,752 | 3,950 | 2,326 |
| Cost of Goods | 2,604 | 3,031 | 2,732 | 2,243 | 1,708 |
| Gross Profit | 1,591 | 1,913 | 2,020 | 1,707 | 618 |
| Operating Expenses | 5,716 | 6,123 | 8,208 | 6,660 | 10,126 |
| Operating Income | -4,125 | -4,210 | -6,187 | -4,953 | -9,509 |
| Interest Expense | 58 | 284 | 259 | 56 | 50 |
| Other Income | -2,987 | 80 | -1,327 | -951 | -5,382 |
| Pre-tax Income | -7,171 | -4,415 | -7,773 | -5,960 | -14,942 |
| Income Tax | -326 | -107 | -59 | -160 | -246 |
| Net Income Continuous | -6,845 | -4,308 | -7,714 | -5,801 | -14,695 |
| Minority Interests | 743 | 266 | 87 | 402 | 328 |
| Net Income | $-6,102 | $-4,042 | $-7,627 | $-5,398 | $-14,367 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.02 | -0.01 | -0.04 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.02 | -0.01 | -0.04 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.02 | -0.01 | -0.04 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.02 | -0.01 | -0.04 |
| EBITDA(a) | $-6,754 | $-3,354 | $-6,582 | $-5,274 | $-14,367 |